Skip to content

Stage 3 Pilot Study: a decision tool to improve the management of urinary incontinence in women in the community

Stage 3 Pilot Study: a decision tool to improve the management of urinary incontinence in women in the community

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN89754756
Enrollment
150
Registered
2011-03-18
Start date
2011-04-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care Research Network for England, Renal and Urogenital

Interventions

We seek to recruit at least 60 health care professionals from each of the two study sites and as many patients as present with symptoms of UI during the course of the pilot study. Use of the decision
Details: Patients will not be randomised. It is the health care professionals who will be randomised.

Sponsors

University of York (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthcare professionals: Any healthcare professional who works in a community/primary care setting whose role involves assessment and management of urinary incontinence in women in the community. Health care professionals will be working within two primary care trusts where NHS permissions will be sought for the study to proceed 2. Patients: Women who are over 18 years of age, not pregnant and have symptoms of urinary incontinence are eligible to be invited into the study.; Target Gender: Male & Female ; Lower Age Limit 18 no age limit or unit specified

Exclusion criteria

Exclusion criteria: 1. Health care professionals who were involved in the intial development of the decision tool 2. Patients who are under 18 years of age 3. Patients who are pregnant 4. Patients who are unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Amelioration of symptoms of urinary incontinence; Timepoint(s): Baseline, 1 months, 4 months

Secondary

MeasureTime frame
Not provided at the time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026